iSchemaView (doing business as RapidAI)
About iSchemaView (doing business as RapidAI)
RapidAI, doing business as iSchemaView, is a leading healthcare AI company that provides a comprehensive clinical AI platform designed to enhance assessment and transform care across various service lines. For physicians, the Rapid Enterprise™ Platform offers deep clinical decision-making support, particularly in neurovascular, cardiac, and vascular conditions. It leverages artificial intelligence to analyze medical images, such as CT and MRI scans, providing high-quality, automated results and critical insights within minutes. This capability aids in faster, more accurate diagnostic and treatment decisions for conditions like stroke, cerebral aneurysms, and pulmonary embolisms, even extending the treatment window for acute stroke patients based on landmark clinical trials.
The platform goes beyond basic triage and notification by offering interpretive, diagnostic, and predictive information with unparalleled specificity and sensitivity. It integrates seamlessly into hospital workflows via PACS systems and a mobile app, enabling real-time collaboration among care teams, remote access to patient cases, and streamlined communication. RapidAI’s solutions are clinically validated, with numerous FDA clearances, and are utilized in over 2,500 hospitals across more than 100 countries, demonstrating a significant impact on improving patient outcomes and operational efficiencies in emergency neurovascular care and beyond.
Focus Areas
Business Intelligence
| Key Investors | Vista Equity Partners, Cullom Capital, Lennertz & Co., Listwin Ventures, Vista Credit Partners |
| Partnerships | Amazon Web Services (AWS), Saudi Health Holdings Company (HHC) |
| Acquisitions | EndoVantage (June 2020) |
| Technology | Rapid Enterprise™ Platform, Rapid Edge Cloud (hybrid cloud and on-premise infrastructure), AI Orchestrator, Navigator Pro |
| FDA Clearances | Multiple. Specific clearances include: Rapid DeltaFuse™, Rapid LMVO, Rapid MLS, Rapid OH, Rapid Aortic for measurement (5 modules cleared November 2025); Rapid NCCT Stroke (cleared April 2023); Aortic Management (cleared November 2025). cleared products (estimated) |
What Physicians Need to Know
RapidAI empowers physicians by providing real-time, actionable insights that lead to faster, more confident clinical decisions and improved patient outcomes. The platform significantly reduces cognitive burden by automating measurements, visualizing anomalies, and pre-fetching relevant data, allowing physicians to focus on interpretation and clinical judgment. Its integrated workflow solutions facilitate seamless communication and coordination across multidisciplinary care teams, from the ER to the OR and beyond. Physicians benefit from a comprehensive view of patient data, including automated 3D renderings and longitudinal tracking, which supports both acute treatment and long-term patient management. The clinically validated nature of RapidAI's algorithms, backed by extensive research, instills trust and helps expand treatment windows and guidelines.
RapidAI's Enterprise Platform is designed for seamless integration across the healthcare ecosystem. It connects directly with existing IT infrastructure, including PACS, EHR, RIS, worklists, and reporting systems, ensuring a unified experience rather than adding another layer to manage. The platform also supports the integration of curated third-party AI algorithms, expanding its capabilities and providing a comprehensive suite of tools within a single workflow. The Rapid Edge Cloud, a hybrid infrastructure, ensures secure, reliable, and scalable deployment, meeting complex regional security, compliance, and data privacy requirements.
What the Web Says
RapidAI (iSchemaView) generally receives positive reviews for its AI-powered stroke analysis software, which is praised for its speed, accuracy, and impact on patient outcomes. Employer reviews are mixed, with some highlighting a positive culture and others pointing to challenges with management and work-life balance.
Overall: MixedStrengths
- RapidAI's stroke analysis software is highly effective, fast, and accurate, significantly improving treatment times and patient outcomes.
- The software is user-friendly and integrates well into existing hospital workflows.
- Many users appreciate the company's commitment to innovation in healthcare technology.
- Some employees praise the company culture, intelligent colleagues, and the meaningful impact of their work.
- The product is considered a valuable tool for neurologists and stroke teams.
- Good benefits package for employees.
Limitations
- Some employer reviews mention issues with management, communication, and lack of clear direction.
- Work-life balance can be a challenge for some employees, with long hours reported.
- Rapid growth has led to some organizational growing pains and changes.
- Specific pricing details or cost-effectiveness are not always highlighted as a pro, suggesting it might be a consideration for some institutions.
- Some users on Reddit express concerns about the proprietary nature of the software and potential vendor lock-in.
- Limited negative product reviews, but some minor UI/UX suggestions have been noted.
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (implied from general healthcare IT reviews)
Last updated: 2026-07-20
Videos
News, demos, and interviews about iSchemaView (doing business as RapidAI).
Videos load interactively. If none appear, search YouTube for iSchemaView (doing business as RapidAI) →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]